ASTRIA THERAPEUTICS INC's ticker is and the CUSIP is 04635X102. A total of 44 filers reported holding ASTRIA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $229,388 | +121.5% | 30,749 | +147.3% | 0.00% | – |
| Q2 2023 | $103,584 | -68.8% | 12,435 | -50.2% | 0.00% | – |
| Q1 2023 | $332,287 | -86.0% | 24,984 | -84.3% | 0.00% | – |
| Q4 2022 | $2,372,662 | +114.1% | 159,346 | +30.1% | 0.00% | – |
| Q3 2022 | $1,108,000 | +24.1% | 122,476 | -58.9% | 0.00% | – |
| Q2 2022 | $893,000 | -69.3% | 297,862 | -31.2% | 0.00% | – |
| Q1 2022 | $2,905,000 | +13.7% | 432,889 | -8.7% | 0.00% | – |
| Q4 2021 | $2,556,000 | -6.9% | 474,273 | +52.7% | 0.00% | -100.0% |
| Q3 2021 | $2,746,000 | – | 310,589 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 911,736 | $8,060,000 | 2.93% |
| VR Adviser, LLC | 538,999 | $4,765,000 | 0.61% |
| COMMODORE CAPITAL LP | 239,270 | $2,115,000 | 0.56% |
| Perceptive Advisors | 1,959,652 | $17,323,000 | 0.25% |
| Cormorant Asset Management, LP | 552,903 | $4,888,000 | 0.20% |
| RA Capital Management | 1,262,193 | $11,158,000 | 0.16% |
| Soleus Capital Management, L.P. | 112,499 | $994,000 | 0.16% |
| ArchPoint Investors | 28,247 | $250,000 | 0.08% |
| Ikarian Capital, LLC | 87,580 | $775,000 | 0.06% |
| Old Well Partners, LLC | 12,116 | $107,000 | 0.06% |